VTRS
ViatrisANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
VTRS vs peer average
77/100
VTRS vs. peer average (A vs. C)
Grade spread
A 1 · B 4 · C 2 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Useful as a mature biotech/pharma cash-generation peer, but the mix is much more innovation-heavy and less generic-driven than Viatris.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VTRS
Viatris
AMGN
Amgen
Grade
A
D
Momentum
90
94
Value
65
61
Sentiment
50
26
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
VTRS / AMGN
Grade Position
Above peers
VTRS vs. peer average (A vs. C)
77/100
Momentum
90
AMGNValue
65
VTRSSentiment
50
VTRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VTRS
AMGN is the first peer returned for this comparison set.